Regulations and Licensures - References

  1. American Society for Clinical Pathology (ASCP). Technologist in Cytotechnology, CT(ASCP), Specialist in Cytotechnology, SCT(ASCP) – Examination Content Guideline. Available at:
  2. American Society for Clinical Pathology (ASCP). Technologist in Molecular Pathology, MP(ASCP) – Examination Content Guideline. Available at:
  3. American Society for Colposcopy and Cervical Pathology (ASCCP) Algorithms for the management of women with abnormal cervical cancer screening tests. Available at:
  4. American Society of Cytopathology (ASC). Cytology Education and Technology Consortium. Statement on HPV DNA Test Utilization. 2007.
  5. American Society of Cytopathology (ASC). Cytotechnologist State Licensure: Proposal to State Legislatures, November 7, 2006. Includes proposed scope of practice for cytotechnologists (e.g., Prepare patient specimens according to standard operating procedures for ancillary testing, including but not limited to in situ hybridization, immunocytochemistry, and amplified nucleic acid detection). Available at:
  6. Blond B. CAP HPV Survey to begin soon. CAP Today, February 2008. Available at:
  7. California Association of Cytotechnologists. Website available at:
  8. Center for Medicare & Medicaid Services (CMS). 42 CFR Chapter IV. (10-1-04 Edition [current]), Part 493. Laboratory Requirements. (CLIA '88). Available at:
  9. College of American Pathologists (CAP). Molecular Pathology Checklist. Available at:
  10. Commission on Accreditation of Allied Health Education Programs (CAAHEP). Standards and Guidelines for the Accreditation of Educational Programs in Cytotechnology. Revised 2004. Does not include any specific curriculum content such as molecular testing or even Pap smear screening. Available at:
  11. Crothers B, Banks H, Berry A, Mueller G, Bentz JS, Gill GW, Navin J. Cytotechnologist State Licensure Information Bulletin. May 2006. Available at:
  12. Moriarty AT, DuBray-Benstein B. The upsides and downsides of state licensure for cytotechnologists. CAP Today, January 2005. Available at:
  13. Moriarty AT, Schwartz MR, Eversole G, Means M, Clayton A, Souers R, Fatheree L, Tench WD, Henry M, Wilbur DC. Human papillomavirus testing and reporting rates: practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006. Arch Pathol Lab Med. 2008;132(8):1290-4.
  14. Snijders PJ, van den Brule AJ, Meijer CJ. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol. 2003;201(1):1-6.
  15. State Survey Agencies (CLIA Contact List). Available at:
  16. Wright TC, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obs Gynecol. 2007;187(4):346-55. Available at: